Impacts of MR spectroscopic imaging on glioma patient management

Authors

  • Ioanna Chronaiou Radiography Department, Faculty of Technology (AFT), Sør-Trøndelag University College (HiST), Trondheim, Norway; Department of Circulation and Medical Imaging, Norwegian University of Science and Technology (NTNU), Trondheim, Norway
  • Anne Line Stensjøen Department of Circulation and Medical Imaging, Norwegian University of Science and Technology (NTNU), Trondheim, Norway
  • Torill Eidhammer Sjøbakk Department of Circulation and Medical Imaging, Norwegian University of Science and Technology (NTNU), Trondheim, Norway
  • Morteza Esmaeili Department of Circulation and Medical Imaging, Norwegian University of Science and Technology (NTNU), Trondheim, Norway
  • Tone Frost Bathen Department of Circulation and Medical Imaging, Norwegian University of Science and Technology (NTNU), Trondheim, Norway

DOI:

https://doi.org/10.3109/0284186X.2014.891046

Abstract

Magnetic resonance (MR) modalities are routine imaging tools in the diagnosis and management of gliomas. MR spectroscopic imaging (MRSI), which relies on the metabolic characteristics of tissues, has been developed to accelerate the understanding of gliomas and to aid in effective clinical decision making and development of targeted therapies. In this review, the potentials and practical challenges to frequently use this technique in clinical management of gliomas are discussed. The applications of new biomarkers detectable by MRSI in differential glioma diagnosis, pre- and post-treatment evaluations, and neurosurgery are also addressed.

Downloads

Download data is not yet available.

Downloads

Published

2014-05-01

How to Cite

Chronaiou, I., Line Stensjøen, A., Eidhammer Sjøbakk, T., Esmaeili, M., & Frost Bathen, T. (2014). Impacts of MR spectroscopic imaging on glioma patient management. Acta Oncologica, 53(5), 580–589. https://doi.org/10.3109/0284186X.2014.891046

Issue

Vol. 53 No. 5 (2014): Acta Oncologica

Section

Articles